Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unlicensed Cord Blood Units for Hematologic Malignancies
NCT01479582Phase 2Withdrawn
- Sponsor
- National Cancer Institute
- Start
- Oct 2011
- Primary completion
- Nov 2012
01
Overview
A Phase 2 trial of unlicensed cryopreserved cord blood units in hematologic malignancy, lysosomal storage disorder (LSD), Peroxisomal enzyme deficiency (PED), Hurler syndrome, Krabbe disease, sponsored by National Cancer Institute. Planned start Oct 2011; status: withdrawn.
02
Drugs
unlicensed cryopreserved cord blood units
03
Conditions
hematologic malignancylysosomal storage disorder (LSD)Peroxisomal enzyme deficiency (PED)Hurler syndromeKrabbe disease
Beyond the preview
Go deeper on NCT01479582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479582.